A recent opinion piece in The Economist discusses a very polarizing topic whether patents granted to pharmaceutical companies help or discourage innovation in biomedical research.
Unlike reflexive reactions of many other groups and commentators, who somehow think that it is fair to take intellectual property away from one particular industry, the Economist article recognizes that this is impossible, that is, if we ever want to see a new drug again.
A recent opinion piece in The Economist discusses a very polarizing topic whether patents granted to pharmaceutical companies help or discourage innovation in biomedical research.
Unlike reflexive reactions of many other groups and commentators, who somehow think that it is fair to take intellectual property away from one particular industry, the Economist article recognizes that this is impossible, that is, if we ever want to see a new drug again.